206 related articles for article (PubMed ID: 19822494)
1. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic expression and quantitative analysis of hepatic nuclear factor-kappa B and its gene during the development of hepatocellular carcinoma].
Dong ZZ; Yao DF; Yu HB; Gu WJ; Shen YC; Li YM; Wang YL; Shen JJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):669-73. PubMed ID: 18822207
[TBL] [Abstract][Full Text] [Related]
4. Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats.
Dong ZZ; Yao DF; Wu W; Yao M; Yu HB; Shen JJ; Qiu LW; Yao NH; Sai WL; Yang JL
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):169-74. PubMed ID: 20382589
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
[TBL] [Abstract][Full Text] [Related]
6. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
Zhou WM; Ping JL; Qian FC; Zhang GL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression of rat heat shock protein gp96 and its gene during development of hepatocellular carcinoma.
Wu XH; Yao DF; Su XQ; Tai BJ; Huang H; Qiu LW; Wu W; Shao YX
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):616-21. PubMed ID: 18086628
[TBL] [Abstract][Full Text] [Related]
8. Activation of NF-kappaB and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.
Sánchez A; Factor VM; Schroeder IS; Nagy P; Thorgeirsson SS
Hepatology; 2004 Feb; 39(2):376-85. PubMed ID: 14767990
[TBL] [Abstract][Full Text] [Related]
9. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis.
Alwahaibi NY; Budin SB; Mohamed J; Alhamdani A
J Gastroenterol Hepatol; 2010 Apr; 25(4):786-91. PubMed ID: 20492335
[TBL] [Abstract][Full Text] [Related]
11. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
[TBL] [Abstract][Full Text] [Related]
13. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
15. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
[TBL] [Abstract][Full Text] [Related]
16. [An evaluation of transforming growth factor-beta 1 in diagnosing hepatocellular carcinoma and metastasis].
Dong ZZ; Yao DF; Zou L; Yao M; Qiu LW; Wu XH; Wu W
Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):503-8. PubMed ID: 17669238
[TBL] [Abstract][Full Text] [Related]
17. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation.
Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF
World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410
[TBL] [Abstract][Full Text] [Related]
19. The role of NF-kappaB in hepatocellular carcinoma cell.
Wang J; Huang Q; Chen M
Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
